Cisplatin/Paclitaxel/Gemcitabine +/- Avastin in Patients With Unknown Primary Tumor
Status:
Withdrawn
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy of Cisplatin, Paclitaxel,
Gemcitabine +/- Avastin (Bevacizumab) in patients with unknown primary tumors.